NHS patients to get easier access to MS pill after NICE reth...

Patients in England are to get easier access to Merck KGaA’s multiple sclerosis drug Mavenclad after NICE dropped requirements for a special MRI scan before prescription.

Chasing Mylan, Hikma tries again with rejected generic Advai...

Trump's reps 'pushed hard' for UK drug price reforms, leaked...

Representatives of the Trump administration have “pushed hard” for pro-US drug pricing reforms in free trade negotiations with the UK government, according to leaked documents posted online

FDA rejects Adamis opioid overdose therapy Zimhi, hitting sh...

FDA cues up May verdict for Roche’s SMA challenger risdiplam

Corbyn pledges to create state-run generics firm to cut drug...

Labour leader Jeremy Corbyn has included in the party’s election manifesto plans to create a state-run generic drug company to combat excessively high prices for new medicines.